Skip Navigation LinksHome > July 2007 - Volume 86 - Issue 7 > Amantadine Treatment of Hemispatial Neglect: A Double-Blind,...
American Journal of Physical Medicine & Rehabilitation:
doi: 10.1097/PHM.0b013e31806e3392
Special Section: Research Article: Brain Injury

Amantadine Treatment of Hemispatial Neglect: A Double-Blind, Placebo-Controlled Study

Buxbaum, Laurel J. PsyD; Ferraro, Mary PhD; Whyte, John MD, PhD; Gershkoff, Arthur MD; Coslett, H Branch MD

Collapse Box


Buxbaum LJ, Ferraro M, Whyte J, Gershkoff A, Coslett HB: Amantadine treatment of hemispatial neglect: a double-blind, placebo-controlled study. Am J Phys Med Rehabil 2007;86:527–537.

Objective: The resemblance of some aspects of the hemispatial neglect syndrome (hypokinesia, decreased arousal) to aspects of Parkinsonian syndromes, and the success of amantadine in treating disorders of attention, prompted a placebo-controlled, double-blind trial of amantadine, an inhibitor of the N-methyl d-aspartate (NMDA) glutamate receptor that modulates dopamine transmission, in four patients with chronic hemispatial neglect.

Design: Patients received placebo or 100 mg of amantadine twice a day in an ABA design. Dependent measures of drug effect included an extensive battery of tests assessing arousal, hemiinattention, hemihypokinesia, personal neglect, disability, anosognosia, family burden, and naturalistic action.

Results: There was no evidence of increased adverse effects with the treatment drug compared with placebo. Of the 17 measures used to assess treatment response in the four patients (68 measures total), linear regressions revealed significant positive treatment effects on very few (four) measures (uncorrected for multiple comparisons), and scattered negative responses to treatment were evident on three measures. The vast majority of measures showed no change in response to treatment.

Conclusions: Possible reasons for failure of treatment effects in the present study are discussed. Additional study will be required to determine whether there are neglect patients who may benefit from amantadine.

© 2007 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.